Long term objectives are: 1) to understand mechanisms of genes and processes involved in neonatal lung disease in order to help identify specific targets for therapeutic intervention;and 2) to use genetic markers to identify prematurely born infants at risk for acute lung disease who would best respond to a targeted therapy early in their course of treatment or that could make good subjects in future novel drug/therapy trials. Surfactant protein (SP) genetic variants and low levels of SPs are associated with neonatal lung disease, respiratory distress syndrome (RDS or acute lung disease) or bronchopulmonary dysplasia (BPD or chronic lung disease). SPs play important roles in both normal lung function and innate host defense. Although maternal steroid therapy is widely used to avoid lung disease in infants born prematurely, not all fetal lungs respond and the long-term consequences are not fully understood. The general hypothesis under investigation states that multiple genetic factors contribute to the development of neonatal lung disease and RDS in particular. The goal in this application is to study regulatory mechanisms of human SPs shown to associate with neonatal lung disease (including RDS) and perform a genome-wide search of candidate genes for associations with RDS.
The Specific Aims i nclude the study of SP-A 5'UTR splice variants on translational regulation of human SP-A1 and SP-A2 by investigating trans- and cis- acting factors (Aim 1);the role of SP-B intron 4 variants on splicing by investigating the importance of sequence composition and size of intron, and by studying cis-acting elements (Aim 2);and genome-wide candidate genes associations with neonatal lung disease in a case (RDS)-control study by using a high throughput approach for genotyping tag single nucleotide polymorphisms (tag SNPs), as well as ancestry-informative SNP markers to quantitatively measure an individual's admixture estimate (IAE). A study of gene-gene and gene-environment interactions will be done by performing logistic regression analyses where SNP genotypes are used as independent variables and environmental factors (i.e. gestational age, weight, IAE, sex, maternal steroid treatment, and surfactant therapy) are included as covariates (Aim 3). The overall information obtained is likely to make significant contributions not only to the long-term objectives stated above, but also to lung diseases beyond neonatal lung disease. The physiologic importance of SPs in lung function and host defense places them at center stage for several lung diseases because most (if not all) of lung diseases are identified with derangements in either process. The significant findings from the genome-wide search of candidate genes will provide a solid foundation for future studies where evidence-based hypotheses can be investigated and may also provide insight (based on the location and characteristics of the SNPs that define the significant haplotypes) as to which of these genes contribute to RDS via a regulatory or functional derangement.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL034788-24
Application #
8097349
Study Section
Respiratory Integrative Biology and Translational Research Study Section (RIBT)
Program Officer
Blaisdell, Carol J
Project Start
1991-08-12
Project End
2013-06-30
Budget Start
2011-07-01
Budget End
2013-06-30
Support Year
24
Fiscal Year
2011
Total Cost
$603,462
Indirect Cost
Name
Pennsylvania State University
Department
Physiology
Type
Schools of Medicine
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
Tsotakos, Nikolaos; Phelps, David S; Yengo, Christopher M et al. (2016) Single-cell analysis reveals differential regulation of the alveolar macrophage actin cytoskeleton by surfactant proteins A1 and A2: implications of sex and aging. Biol Sex Differ 7:18
Lopez-Rodriguez, Elena; Pascual, Alicia; Arroyo, Raquel et al. (2016) Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films. Biophys J 111:524-536
Yang, Linlin; Carrillo, Marykate; Wu, Yuchieh M et al. (2015) SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation. PLoS One 10:e0126576
Tsotakos, Nikolaos; Silveyra, Patricia; Lin, Zhenwu et al. (2015) Regulation of translation by upstream translation initiation codons of surfactant protein A1 splice variants. Am J Physiol Lung Cell Mol Physiol 308:L58-75
Noutsios, Georgios T; Ghattas, Paul; Bennett, Stephanie et al. (2015) 14-3-3 isoforms bind directly exon B of the 5'-UTR of human surfactant protein A2 mRNA. Am J Physiol Lung Cell Mol Physiol 309:L147-57
Quintanilla, Hector D; Liu, Yuying; Fatheree, Nicole Y et al. (2015) Oral administration of surfactant protein-a reduces pathology in an experimental model of necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 60:613-20
Grageda, Melissa; Silveyra, Patricia; Thomas, Neal J et al. (2015) DNA methylation profile and expression of surfactant protein A2 gene in lung cancer. Exp Lung Res 41:93-102
Silveyra, Patricia; Chroneos, Zissis C; DiAngelo, Susan L et al. (2014) Knockdown of Drosha in human alveolar type II cells alters expression of SP-A in culture: a pilot study. Exp Lung Res 40:354-66
Xu, Lihong; Stevens, Janine; Hilton, Mary Beth et al. (2014) COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Sci Transl Med 6:242ra84
Silveyra, Patricia; DiAngelo, Susan L; Floros, Joanna (2014) An 11-nt sequence polymorphism at the 3'UTR of human SFTPA1 and SFTPA2 gene variants differentially affect gene expression levels and miRNA regulation in cell culture. Am J Physiol Lung Cell Mol Physiol 307:L106-19

Showing the most recent 10 out of 58 publications